Clinical-immunological aspects of multiple sclerosis treatment with ethylmethylhydroxypyridine succinate

Popova N.F.; Orlova E.V.; Pashchenkov M.A.; Boĭko A.N.

doi:https://doi.org/

Popova N.F.

kafedra nevrologii i neĭrokhirurgii Rossiĭskogo gosudarstvennogo meditsinskogo universiteta;
gorodskaia klinicheskaia bol'nitsa #11

Orlova E.V.

Pashchenkov M.A.

Boĭko A.N.

KGBUZ "Krasnoiarskiĭ kraevoĭ Tsentr po profilaktike i bor'be so SPID i infektsionnymi zabolevaniiami"

Scopus AuthorID: 57224826008
ORCID: 0000-0001-6476-6417

Clinical-immunological aspects of multiple sclerosis treatment with ethylmethylhydroxypyridine succinate

Authors:

Popova N.F., Orlova E.V., Pashchenkov M.A., Boĭko A.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(8): 53‑56

Read: 847 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Popova NF, Orlova EV, Pashchenkov MA, Boĭko AN. Clinical-immunological aspects of multiple sclerosis treatment with ethylmethylhydroxypyridine succinate. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(8):53‑56. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

References:

Baranov P.A., Appolonova S.A., Rodchenkov G.M. i dr. Vliyanie meksidola na uroven' 6-beta-gidroksikortizola. Klin farmakol 2010; 73: 39-40
Voronina T.A., Smirnov L.D., Goryainova I.I. Mekhanizm deistviya i obosnovanie primeneniya preparata meksidol v nevrologii. M 2002; 14.
Gnezdilova A.V., Gan'shina T.S., Mirzoyan R.S. GAMKergicheskii mekhanizm tserebrovaskulyarnogo effekta meksidola. Klin farmakol 2010; 73: 11-13.
Gusev E.I., Boiko A.N. Rasseyannyi skleroz: ot izucheniya immunopatogeneza k novym metodam lecheniya. M 2001.
Gusev E.I., Boiko A.N., Stolyarov I.D. Rasseyannyi skleroz. M 2009.
Kuzin V.B., Tepaev D.V. Vliyanie preparata meksidol na ryad pokazatelei vegetativnogo statusa i gumoral'nogo immuniteta. Farmateka 2006; 16.
Lutskii M.A. Analiz effektivnosti meksidola v kompleksnom lechenii patsientov s ishemicheskim insul'tom. Nevrol i psikhiat 2010;110: 57-59.
Penionzhkevich D.I., Gorbunov F.E. Novye tekhnologii neirometabolicheskoi terapii tserebrovaskulyarnykh zabolevanii. Nevrol i psikhiat 2009; 7: 19-22.
Podsevatkin V.G., Kiryukhina S.V. Vozmozhnosti primeneniya antioksidantov i antigipoksantov v kompleksnoi terapii obsessivnykh rasstroistv pri razlichnykh psikhicheskikh zabolevaniyakh. Nevrol i psikhiat 2010; 3: 56-61.
Yasnetsov V.V., Voronina T.A. Antigipoksicheskie i antiamnesticheskie effekty meksidola i semaksa. Klin farmakol 2010; 73: 2-7.